IRIS
Carlo Stella, Carmelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.361
AS - Asia 6.812
EU - Europa 2.165
SA - Sud America 1.205
AF - Africa 313
Continente sconosciuto - Info sul continente non disponibili 254
OC - Oceania 14
Totale 24.124
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.019
SG - Singapore 4.433
CN - Cina 980
BR - Brasile 968
VN - Vietnam 646
IT - Italia 515
FI - Finlandia 372
DE - Germania 259
IE - Irlanda 254
NG - Nigeria 207
HK - Hong Kong 205
CA - Canada 193
FR - Francia 168
GB - Regno Unito 160
IN - India 101
NL - Olanda 80
AR - Argentina 72
MX - Messico 70
BD - Bangladesh 58
TR - Turchia 56
RU - Federazione Russa 53
IQ - Iraq 48
SE - Svezia 45
EC - Ecuador 37
ES - Italia 36
CZ - Repubblica Ceca 31
PK - Pakistan 30
CL - Cile 28
CO - Colombia 28
IL - Israele 28
UA - Ucraina 28
PL - Polonia 27
BE - Belgio 26
ID - Indonesia 25
ZA - Sudafrica 22
JP - Giappone 21
PY - Paraguay 21
SA - Arabia Saudita 20
UZ - Uzbekistan 20
VE - Venezuela 19
LT - Lituania 18
MA - Marocco 18
PH - Filippine 18
EG - Egitto 16
AT - Austria 15
PE - Perù 15
MY - Malesia 14
JO - Giordania 13
KE - Kenya 13
CR - Costa Rica 12
NP - Nepal 12
RO - Romania 12
TN - Tunisia 12
UY - Uruguay 12
JM - Giamaica 11
TT - Trinidad e Tobago 11
AU - Australia 10
KR - Corea 10
DO - Repubblica Dominicana 9
HN - Honduras 9
AZ - Azerbaigian 8
GR - Grecia 8
IR - Iran 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
CH - Svizzera 7
DZ - Algeria 7
GT - Guatemala 7
DK - Danimarca 6
TH - Thailandia 6
AM - Armenia 5
ET - Etiopia 5
LK - Sri Lanka 5
LV - Lettonia 5
SY - Repubblica araba siriana 5
BO - Bolivia 4
EE - Estonia 4
HR - Croazia 4
KZ - Kazakistan 4
LB - Libano 4
NI - Nicaragua 4
NO - Norvegia 4
OM - Oman 4
SN - Senegal 4
SV - El Salvador 4
GE - Georgia 3
HU - Ungheria 3
MD - Moldavia 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
GA - Gabon 2
KH - Cambogia 2
KW - Kuwait 2
NZ - Nuova Zelanda 2
Totale 23.846
Salva come PNG Salva come JPEG
Città #
Singapore 2.007
Wilmington 1.329
Chandler 1.275
Ashburn 1.096
San Jose 712
The Dalles 687
Dallas 653
San Mateo 505
Shanghai 482
Helsinki 366
Council Bluffs 351
Ann Arbor 335
Dublin 254
Leawood 244
Boardman 237
Princeton 233
Lawrence 227
New York 215
Benin City 207
Hong Kong 197
Milan 191
Ho Chi Minh City 190
Santa Clara 177
Beijing 176
Hanoi 161
Los Angeles 147
Fairfield 125
Paris 123
Woodbridge 98
Toronto 88
Rome 83
São Paulo 80
Amsterdam 75
Phoenix 74
Columbus 72
London 66
Buffalo 60
Seattle 60
San Diego 42
Da Nang 40
Chicago 38
Brooklyn 35
Houston 35
North Bergen 35
Atlanta 33
Rio de Janeiro 33
Montreal 32
Naples 31
Norwalk 31
Philadelphia 31
Munich 28
Brussels 26
Falls Church 26
Orem 26
Brasília 23
Brno 23
San Francisco 23
Falkenstein 22
Warsaw 22
Denver 21
Haiphong 21
Belo Horizonte 20
Charlotte 20
Tashkent 20
Miami 19
Campinas 18
Frankfurt am Main 18
Las Vegas 18
Washington 18
Arizona City 17
Bar Harbor 17
Richmond 17
Curitiba 16
Figino 16
Guayaquil 16
Newark 16
Can Tho 15
Cleveland 15
Dhaka 15
Kocaeli 15
The Bronx 15
Biên Hòa 14
Boston 14
Chennai 14
Cincinnati 14
Mexico City 14
Stockholm 14
Tokyo 14
Turin 14
Amman 13
Baghdad 13
Monmouth Junction 13
Moscow 13
Pune 13
Queens 13
Gunzenhausen 12
Orlando 12
Istanbul 11
Johannesburg 11
Kuala Lumpur 11
Totale 14.923
Salva come PNG Salva come JPEG
Nome #
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis 185
Primary refractory and early-relapsed Hodgkin's lymphoma : strategies for therapeutic targeting based on the tumour microenvironment 174
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogenic stem call transplantation from a HLA identical sibling 166
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®) 160
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH) 153
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma 147
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 142
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA 137
ACQUIRED CYCLIC THROMBOCYTOPENIATHROMBOCYTOSIS WITH PERIODIC DEFECT OF PLATELET-FUNCTION 132
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 128
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K delta/gamma Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 127
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 127
A case of acute myeloid leukemia, with pseudo-Pelger neutrophils 125
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant 119
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome 119
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation 118
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy 115
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma 115
Tumor-derived PGD2 and NKp30 –B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 114
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma 112
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 112
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 111
D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies 111
Amifostine (WR-2721) selective protection against melphalan genotoxicity 108
Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation 107
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial 107
Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis 106
Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses 105
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma 105
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed 104
Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells 103
"Overshoot" phenomenon in circulating granulocytic progenitor cell growth during remission of blast crisis in a case of CML 102
Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy 102
Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice 102
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma : a single institution experience 101
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 101
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection 100
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes 100
[Mesenchymal stem cells: biology and clinical applications] 100
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection 99
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 98
Relapse after glofitamab, a novel unmet medical need with high rates of CD20 loss 97
Detection of maternal progenitor cells in human umbilical cord blood by single-colony karyotyping 97
Deep learning and atlas-based models to streamline the segmentation workflow of total marrow and lymphoid irradiation 96
Radioimmunotherapy and secondary leukemia : a case report 96
Cell therapy: achievements and perspectives 96
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia 95
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade? 95
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies : posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery 95
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells 95
Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment 94
Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-a: evidence for a tyrosine-kinase-dependent process 93
EFFECT OF RECOMBINANT GAMMA-INTERFERON ON THE PROLIFERATIVE ACTIVITY OF CULTURED LEUKEMIC-CELLS 92
Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients 92
AUTOLOGOUS TRANSPLANT FOR CHRONIC MYELOGENOUS LEUKEMIA USING MARROW TREATED EX-VIVO WITH MAFOSFAMIDE 92
Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma 92
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunological responses in indolent B-cell lymphoma patients with relapsed and measurable disease : a pilot study 92
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients 91
Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene 91
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 91
HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL) 91
UMBILICAL-CORD BLOOD AS A SOURCE OF HEMATOPOIETIC STEM-CELLS - FROM RESEARCH TO CLINIC 90
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia : evidence for premature aging of the myeloid compartment 90
Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma 90
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors. 90
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide 90
A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma 89
EFFECT OF RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA ON HUMAN-BONE MARROW DERIVED MEGAKARYOCYTIC PROGENITOR CELLS 89
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts 89
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors : mature results of an Italian randomized phase II study 89
INVITRO MEGAKARYOCYTOPOIESIS IN PATIENTS WITH HIV-RELATED THROMBOCYTOPENIC PURPURA 88
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 88
Outcome after chimeric antigen receptor (CAR) T-cell therapy failure in large B-cell lymphomas 87
Detection of minimal residual disease in hematopoietic progenitor cell harvests : lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma 87
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen) 87
Peripheral Blood Stem Cells versus Bone Marrow for T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma 86
Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders 86
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY 86
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases 86
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma 86
Salvage Therapy for Hodgkin's Lymphoma: A Review of Current Regimens and Outcomes 86
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts 86
Stem cells and stem cell transplantation 85
The novel PI3K-ò inhibitor TGR-1202 enhances brentuximab vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. 85
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma 85
ESTABLISHMENT OF 2 EPSTEIN-BARR VIRUS NEGATIVE BURKITT CELL-LINES FROM A PATIENT WITH AIDS AND B-CELL LYMPHOMA 84
CD34-POSITIVE CELLS - BIOLOGY AND CLINICAL RELEVANCE 84
BIOLOGICAL ASPECTS AND CLINICAL-APPLICATIONS OF LONG-TERM BONE-MARROW CULTURE - A MEETING REPORT 84
Ex vivo manipulation of hematopoietic stem cells for transplantation: The potential role of amifostine 84
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA 84
The anti-HLA-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing NOD/SCID mice 84
The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase 84
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells 84
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation : results from a named patient program at four Italian centers 84
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design 84
[Biological screening of immuno-mediated marrow insufficiency by means of the CFU-GM assay] 83
Phase II study of sorafenib in patients with relapsed or refractory lymphoma 83
Stem cell manipulation: why and how performing peripheral blood progenitor cell purging 83
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice 82
YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation 82
Totale 10.125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 155.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.487
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.192 0 0 0 277 19 20 30 165 132 193 288 68
2022/20233.410 489 104 294 416 327 293 0 311 609 282 237 48
2023/20241.832 139 219 337 41 32 128 69 133 24 37 282 391
2024/20253.391 88 66 33 69 85 329 197 405 538 805 404 372
2025/20268.443 1.250 462 642 745 234 331 2.509 465 468 500 307 530
2026/20273.483 778 891 1.260 554 0 0 0 0 0 0 0 0
Totale 24.124